leucine and Muscular Atrophy, Spinal

leucine has been researched along with Muscular Atrophy, Spinal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, XJ; Ma, L; Mou, Y; Tian, Y; Trinh, J; Wang, Y; Xu, C; Zhang, B; Zhang, X; Zhou, S1
Bird, LE; Cader, MZ; James, PA; Ren, J; Stammers, DK; Talbot, K1

Other Studies

2 other study(ies) available for leucine and Muscular Atrophy, Spinal

ArticleYear
Drug screening with human SMN2 reporter identifies SMN protein stabilizers to correct SMA pathology.
    Life science alliance, 2019, Volume: 2, Issue:2

    Topics: Animals; Blood-Brain Barrier; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Drug Evaluation, Preclinical; Genes, Reporter; HEK293 Cells; Humans; Ketones; Leucine; Mice; Mitochondria; Motor Neurons; Muscular Atrophy, Spinal; Protective Agents; Protein Stability; Proteolysis; Signal Transduction; Survival of Motor Neuron 2 Protein; Transfection; Treatment Outcome

2019
Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy.
    FEBS letters, 2007, Jun-26, Volume: 581, Issue:16

    Topics: Amino Acid Substitution; Binding Sites; Crystallography, X-Ray; Dimerization; Distal Myopathies; Glycine-tRNA Ligase; Humans; Leucine; Models, Molecular; Muscular Atrophy, Spinal; Mutant Proteins; Mutation, Missense; RNA-Binding Proteins; Serine; Transfer RNA Aminoacylation

2007